2.42
-0.29 (-10.70%)
Penutupan Terdahulu | 2.71 |
Buka | 2.68 |
Jumlah Dagangan | 1,487,551 |
Purata Dagangan (3B) | 470,932 |
Modal Pasaran | 87,068,944 |
Harga / Jualan (P/S) | 2.18 |
Harga / Buku (P/B) | 3.58 |
Julat 52 Minggu | |
Tarikh Pendapatan | 4 Aug 2025 - 8 Aug 2025 |
Margin Keuntungan | -15.05% |
Margin Operasi (TTM) | -35.80% |
EPS Cair (TTM) | -0.140 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 161.90% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 38.14% |
Nisbah Semasa (MRQ) | 2.66 |
Aliran Tunai Operasi (OCF TTM) | -2.72 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.37 M |
Pulangan Atas Aset (ROA TTM) | -12.72% |
Pulangan Atas Ekuiti (ROE TTM) | -35.68% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Devices (US) | Menurun | Menurun |
Medical Devices (Global) | Menurun | Menurun | |
Stok | Myomo Inc. | - | - |
AISkor Stockmoo
Konsensus Penganalisis | -2.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 0.5 |
Purata Bergerak Teknikal | 3.5 |
Osilator Teknikal | -2.5 |
Purata | -0.13 |
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals and surgery centers, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts. |
|
Sektor | Healthcare |
Industri | Medical Devices |
% Dimiliki oleh Orang Dalam | 7.05% |
% Dimiliki oleh Institusi | 60.47% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Rosalind Advisors, Inc. | 31 Mar 2025 | 2,703,661 |
Soleus Capital Management, L.P. | 31 Mar 2025 | 704,275 |
Clearstead Advisors, Llc | 31 Mar 2025 | 425,589 |
Stonepine Capital Management, Llc | 31 Mar 2025 | 276,707 |
Manatuck Hill Partners, Llc | 31 Mar 2025 | 275,600 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
18 Jun 2025 | Pengumuman | Myomo Provides Highlights of Today’s Investor & Analyst Day Event |
07 May 2025 | Pengumuman | Myomo Reports First Quarter 2025 Financial and Operating Results |
01 May 2025 | Pengumuman | Myomo to Host Investor & Analyst Day Event on June 18, 2025 |
30 Apr 2025 | Pengumuman | Myomo Launches the MyoPro® 2x |
30 Apr 2025 | Pengumuman | Myomo to Report First Quarter 2025 Financial Results on May 7 |
10 Apr 2025 | Pengumuman | Myomo Announces Upcoming Changes to its Board of Directors |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |